Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Segondy

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
AIDS (London, England)|September 8, 2001
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progressionJ Reynes, P Portales, M Segondy, et al.
Clinical and Experimental Immunology|July 1, 1992
Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosisJ P Vendrell, F Pratlong, A Decoster, et al.
Journal of Clinical Microbiology|July 1, 1993
Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosisJ C Lallement, J P Vendrell, P Corbeau, et al.
Sexually Transmitted Infections|July 4, 2008
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African womenP Mayaud, N Nagot, I Konaté, et al.
The Journal of Infectious Diseases|March 18, 2000
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1J Reynes, P Portales, M Segondy, et al.
Journal of Virological Methods|April 1, 1993
Virus isolation, polymerase chain reaction and in vitro antibody production for the diagnosis of pediatric human immunodeficiency virus infectionA Garbarg-Chenon, M Segondy, A M Conge, et al.
British Journal of Cancer|July 13, 2006
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina FasoM-N Didelot-Rousseau, N Nagot, V Costes-Martineau, et al.
The Journal of Infectious Diseases|July 3, 2008
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levelsN Nagot, A Ouedraogo, I Konate, et al.
Sexually Transmitted Infections|December 7, 2007
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina FasoN Nagot, A Ouedraogo, H A Weiss, et al.
Journal of Clinical Microbiology|January 13, 2004
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-upC Danve-Szatanek, M Aymard, D Thouvenot, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
AIDS (London, England)|September 8, 2001
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progressionJ Reynes, P Portales, M Segondy, et al.
Clinical and Experimental Immunology|July 1, 1992
Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosisJ P Vendrell, F Pratlong, A Decoster, et al.
Journal of Clinical Microbiology|July 1, 1993
Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosisJ C Lallement, J P Vendrell, P Corbeau, et al.
Sexually Transmitted Infections|July 4, 2008
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African womenP Mayaud, N Nagot, I Konaté, et al.
The Journal of Infectious Diseases|March 18, 2000
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1J Reynes, P Portales, M Segondy, et al.
Journal of Virological Methods|April 1, 1993
Virus isolation, polymerase chain reaction and in vitro antibody production for the diagnosis of pediatric human immunodeficiency virus infectionA Garbarg-Chenon, M Segondy, A M Conge, et al.
British Journal of Cancer|July 13, 2006
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina FasoM-N Didelot-Rousseau, N Nagot, V Costes-Martineau, et al.
The Journal of Infectious Diseases|July 3, 2008
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levelsN Nagot, A Ouedraogo, I Konate, et al.
Sexually Transmitted Infections|December 7, 2007
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina FasoN Nagot, A Ouedraogo, H A Weiss, et al.
Journal of Clinical Microbiology|January 13, 2004
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-upC Danve-Szatanek, M Aymard, D Thouvenot, et al.
Pageof 5